Molecular basis of drug-induced immunological liver injury.
D000818:Animals; D000917:Antibody Formation; D000927:Anticonvulsants / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000276:immunology; D004078:Dihydralazine / Q000276:immunology; D064420:Drug-Related Side Effects and Adverse Reactions; D006221:Halothane / Q000009:adverse effects; D006241:Haptens / Q000276:immunology; D006801:Humans; D008099:Liver / Q000276:immunology / Q000378:metabolism; D008107:Liver Diseases / Q000276:immunology*; D013989:Ticrynafen / Q000009:adverse effects
D000927:Anticonvulsants; D006241:Haptens; D013989:Ticrynafen; D004078:Dihydralazine; D006221:Halothane